Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Public ClinicalTrials.gov record NCT02068027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Study identification
- NCT ID
- NCT02068027
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Enrollment
- 260 participants
Conditions and interventions
Interventions
- Clonidine Gel 0.1% Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2014
- Primary completion
- Feb 28, 2015
- Completion
- Feb 28, 2015
- Last update posted
- Sep 25, 2017
2014 – 2015
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Walnut Creek | California | 94598 | — |
| Not listed | Milford | Connecticut | 06460 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | Bradenton | Florida | 34205 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Jupiter | Florida | 33458 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Columbus | Georgia | 31904 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Hazelwood | Missouri | 63042 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | Houston | Texas | 77055 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Virginia Beach | Virginia | 23451 | — |
| Not listed | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02068027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02068027 live on ClinicalTrials.gov.